1. Advances in the Treatment of Behcet’s Disease

   • Fatma Alibaz-Oner
   • Haner Direskeneli

   Vasculitis (C Dejaco and C Duftner, Section Editors) 20 May 2021 Article: 47

2. Correction to: Cognitive Impairment in SLE: Mechanisms and Therapeutic Approaches

   • Aida Zarfeshani
   • Kaitlin R. Carroll
   • Betty Diamond

   Correction 11 May 2021 Article: 46

3. Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update

   • Doruk Erkan
   • Savino Sciascia
   • APS ACTION Executive Committee

   Antiphospholipid Syndrome (S Zuily, Section Editor) 01 May 2021 Article: 45

4. Which Hormones and Contraception for Women with APS? Exogenous Hormone Use in Women with APS

   • Lisa R. Sammaritano

   Antiphospholipid Syndrome (S Zuily, Section Editor) 30 April 2021 Article: 44

5. Exogenous miRNA: A Perspective Role as Therapeutic in Rheumatoid Arthritis

   • Mohd Saquib
   • Prachi Agnihotri
   • Sagarika Biswas

   Rheumatoid Arthritis (L Moreland, Section Editor) 30 April 2021 Article: 43

   

6. Differential Metabolome in Rheumatoid Arthritis: a Brief Perspective

   • Prachi Agnihotri
   • Monu
   • Sagarika Biswas

   Rheumatoid Arthritis (LW Moreland, Section Editor) 28 April 2021 Article: 42

   

7. Fatty Acids and Oxylipins in Osteoarthritis and Rheumatoid Arthritis—a Complex Field with Significant Potential for Future Treatments

   • Anne-Mari Mustonen
   • Petteri Nieminen

   Rheumatoid Arthritis (L Moreland, Section Editor) Open access 28 April 2021 Article: 41

   

8. Drivers of Inflammation in Psoriatic Arthritis: the Old and the New

   • Charlotte O’Brien-Gore
   • Elizabeth H. Gray
   • Bruce W. Kirkham

   Psoriatic Arthritis (J Scher, Section Editor) 28 April 2021 Article: 40

   

9. Reactive Arthritis following Bacillus Calmette–Guerin Therapy for Bladder Cancer: a Systematic Literature Review

   • Kawther Ben Abdelghani
   • Lilia Nacef
   • Ahmed Laatar

   Reactive Arthritis (H Zeidler, Section Editor) 28 April 2021 Article: 39

   

10. Novel Therapies for ANCA-associated Vasculitis

    • Sara Monti
    • Fabio Brandolino
    • Carlomaurizio Montecucco

    Vasculitis (C Dejaco and C Duftner, Section Editors) 28 April 2021 Article: 38

    

11. ANCA Status or Clinical Phenotype — What Counts More?

    • Martin Windpessl
    • Erica L. Bettac
    • Andreas Kronbichler

    Vasculitis (C Dejaco and C Duftner, Section Editors) Open access 28 April 2021 Article: 37

12. Value-Based Healthcare in Rheumatology: Axial Spondyloarthritis and Beyond

    • David F. L. Liew
    • Jonathan Dau
    • Philip C. Robinson

    Spondyloarthritis (M Khan, Section Editor) 28 April 2021 Article: 36

13. Axial Psoriatic Arthritis

    • Dafna D. Gladman

    Spondyloarthritis (M Khan, Section Editor) 28 April 2021 Article: 35

14. JAK Inhibitors for Axial Spondyloarthritis: What does the Future Hold?

    • Nurullah Akkoc
    • Muhammad A. Khan

    Spondyloarthritis (M Khan, Section Editor) 28 April 2021 Article: 34

    

15. Neuromyelitis Optica Spectrum Disorders (NMOSD) and Connective Tissue Disease (CTD): an Update for the Rheumatologist

    • Roberto A. Cruz
    • Sana Chaudhary
    • Ethan Meltzer

    Systemic Lupus Erythematosus (G Tsokos, Section Editor) 28 April 2021 Article: 33